Africa Current Affairs - 2019

Category Wise PDF Compilations available at This Link

World’s first Malaria Vaccine launched in Malawi, Africa

World’s first Malaria Vaccine named RTS,S (trade name Mosquirix) was launched in Malawi, Africa on occasion of World Malaria Day (observed on 25 April). It was launched as part of pilot programme aimed at immunizing children aged 2 years and below in three African countries Malawi, Ghana and Kenya. Other two countries will launch this vaccine in coming weeks.

About Pilot Programme

  • It is World Health Organization (WHO) coordinated three country pilot programme where risk of malaria is high. It aims to vaccinate 360,000 children per year with RTS,S vaccine across three countries and give them partial protection against disease. Children will be vaccinated on time with 4 required doses.
  • The pilot programme is financed by collaboration of three key global health funding bodies: Gavi ( a public-private partnership Global Vaccine Alliance), Global Fund to Fight AIDS, Tuberculosis and Malaria, and Unitaid (global health initiative that works with partners to end world’s tuberculosis, HIV/AIDS, malaria and hepatitis C epidemics). Also, WHO, PATH and GSK will provide in-kind contributions.

About RTS,S Vaccine

  • It is recombinant protein-based malaria vaccine. It is world’s first and only malaria vaccine. Its trade name is Mosquirix.
  • It has been developed and manufactured by British drugmaker GlaxoSmithKline (GSK) in partnership with the PATH Malaria Vaccine Initiative.
  • It provides protection to only a third of children of less than 2 years age from severe malaria.
  • It will act as complementary malaria control tool besides WHO-recommended core measures for malaria prevention, like routinely using insecticide-treated bed nets, indoor insecticides spraying and timely malaria testing and treatment.

 About Malaria

  • It is a life-threatening disease caused by parasites, which are transmitted by bites of infected female Anopheles mosquitoes. It is one of world’s leading killer disease. It is preventable and curable.
  • In 2017, about 219 million cases of malaria were reported in 87 countries, and number of malaria deaths was 435 000.
  • According to WHO, African Region carries highest share of global malaria burden with home to 92% of malaria cases and 93% of malaria deaths in 2017.

 

Malawi to Test Groundbreaking Malaria Vaccine

African Nation, Malawi will be undertaking large scale pilot tests for the world’s most advanced experimental malaria vaccine in a bid to prevent the disease that kills hundreds of thousands across Africa and Asia every year.

Vaccine for Malaria

  • Vaccine for Malaria under the trade name Mosquirix has been developed by British pharmaceutical giant GlaxoSmithKline in partnership with the PATH Malaria Vaccine Initiative.
  • Four successive doses of the vaccines must be administered on a strict timetable for it to work.
  • Even though the potential vaccine does not give full protection against the mosquito-borne disease, it is the furthest along in development and so far the most effective.
  • The pilot tests aim to immunize around 120,000 children aged 2 and below to assess the effectiveness of the pilot vaccine and whether the delivery process is feasible.

Malaria which spreads to people through the bites of infected female Anopheles mosquitoes has killed 435,000 people in 2017 alone and the majority of them were children under 5 in Africa.